The key finding
The 2025 European Society of Cardiology guidelines for peripheral arterial disease (PAD) represent a fundamental shift in treatment philosophy. Rather than focusing solely on improving blood flow to the legs, the new approach treats PAD as a window into systemic cardiovascular risk. The guidelines emphasize that managing traditional and non-traditional risk factors—through lifestyle changes and tailored medications—is just as important as addressing limb symptoms. For patients with exertional leg pain, supervised exercise training is now a cornerstone recommendation, and invasive procedures are reserved primarily for limb salvage in severe cases or for carefully selected patients who don’t improve with optimal medical therapy.
What the study looked like
This publication is not a primary research study but a coordinated summary of the newly released European Society of Cardiology guidelines for peripheral arterial and aortic diseases, endorsed by the European Society of Vascular Medicine. The summary was written by the Young Academy of the European Society of Vascular Medicine to help early-career vascular specialists navigate the comprehensive recommendations. The guidelines themselves synthesize evidence from multiple studies and expert consensus to create a multidisciplinary framework for diagnosing, treating, and following patients with PAD. The document covers the full spectrum of disease—from asymptomatic patients to those with chronic limb-threatening ischemia—and integrates input from cardiologists, vascular surgeons, radiologists, and other specialists.
Why researchers think this happened
The shift toward a holistic, prevention-focused approach reflects growing recognition that PAD is rarely an isolated problem. Patients with blocked leg arteries often have atherosclerosis in coronary and carotid vessels as well, placing them at elevated risk for heart attack and stroke. The guideline authors argue that reducing overall atherosclerotic burden—not just improving walking distance—should be the primary goal. This means aggressively managing cholesterol, blood pressure, diabetes, and smoking, while also addressing emerging risk factors like inflammation. The emphasis on supervised exercise stems from robust evidence that structured physical activity improves symptoms, quality of life, and possibly even survival, often matching or exceeding the benefits of angioplasty or stenting in patients with milder disease. By reserving invasive procedures for limb salvage or refractory cases, the guidelines aim to reduce procedural complications and align treatment intensity with disease severity.
How to read this carefully
These are consensus guidelines, not the results of a single controlled trial. They synthesize evidence of varying quality—from randomized trials to observational studies to expert opinion—so recommendations carry different levels of certainty. The summary targets young specialists and may not capture every nuance of the full guideline document. Importantly, the European guidelines may differ from those issued by American or other international societies, reflecting regional practice patterns and available resources. The emphasis on supervised exercise, for example, requires access to trained personnel and facilities, which may not be universally available. Finally, while the guidelines stress shared decision-making and multidisciplinary care, real-world implementation depends heavily on local infrastructure, reimbursement policies, and care coordination.
What this means for everyday life
If you or someone you know has been diagnosed with PAD—or experiences leg pain when walking that improves with rest—this guideline update suggests that treatment should extend well beyond the legs. It may be worth asking your doctor not only about procedures to open blocked arteries but also about a comprehensive plan to lower cardiovascular risk: optimizing medications for cholesterol and blood pressure, quitting smoking, and participating in a supervised exercise program if available. The new emphasis on exercise as a first-line therapy is particularly empowering, as it offers patients an active role in their own care. For those facing possible surgery or stenting, the guidelines support seeking a second opinion or multidisciplinary evaluation to ensure the intervention is truly necessary and that less invasive options have been fully explored.